Your search for apixaban returned 88 results

Risk up with amiodarone vs flecainide or sotalol among seniors with atrial fibrillation receiving apixaban or rivaroxaban.

Asundexian is an investigational oral Factor XIa inhibitor.

Apixaban dominated enoxaparin and edoxaban; rivaroxaban was slightly more effective than apixaban

No substantial differences seen for other outcomes or for other direct oral anticoagulant comparisons

Apixaban and rivaroxaban are both factor Xa inhibitors.

Fewer compliance events seen with apixaban versus enoxaparin for extended-duration VTE prophylaxis after abdominopelvic oncologic surgery

Abelacimab is a highly selective, fully human monoclonal antibody designed to inhibit both factor XI and its activated form, factor XIa.

Apixaban is a direct oral anticoagulant that relies less on kidney excretion.

Direct oral anticoagulants reduce recurrent VTE events by 41 percent, with no significant increase in major bleeding, compared to dalteparin

Among new users, rates of recurrent venous thromboembolism, GI and intracranial bleeding lower with apixaban than rivaroxaban